Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:January 22, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:January 22, 2020Completed
Condition(s):NAFLD – Nonalcoholic Fatty Liver Disease; NASH – Nonalcoholic SteatohepatitisLast Updated:September 27, 2021Withdrawn
Condition(s):Non-Alcoholic Fatty Liver Disease; Obese; OverweightLast Updated:June 12, 2017Unknown status
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:March 21, 2019Unknown status
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:April 15, 2021Completed
Condition(s):Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis PatientsLast Updated:April 12, 2023Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 10, 2010Unknown status
Condition(s):Non-alcoholic Fatty Liver Disease; Chronic Kidney Disease; Diabetes MellitusLast Updated:February 25, 2019Unknown status
Condition(s):Type 2 Diabetes; Nonalcoholic Fatty LiverLast Updated:September 29, 2020Completed
Condition(s):NASH; NAFLD; Non-alcoholic Fatty Liver; Non-Alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; Fatty Liver; Fatty Liver DiseaseLast Updated:March 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.